Those looking for a bit of good news to start the week may have to cast the net further out. Stock futures are tilting lower as COVID-19 cases flare up in China, threatening more lockdowns.
“This is a very important season as the collapse in equities so far in 2022 is largely due to margin compression [costs rise for companies that can’t pass onto consumers] and not really earnings weakness,” said a team of strategists led by Jim Reid at Deutsche Bank. The SPDR S&P Biotech ETF XBI is around 36% off its lows, and maybe there is more room to run here, but “near-term risk/reward is hard to defend,” he said, adding that he also sees some charts of highflying auto components companies, who have been in the grips of a strong rally, looking vulnerable.
Shanghai officials have detected the highly contagious new Omicron BA.5 coronavirus subvariant, which is spreading fast across India.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: WSJ - 🏆 98. / 63 Прочитайте больше »
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »